Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emricasan in Post-Transplant HCV Fibrosis
NCT02138253Phase 2Completed
- Sponsor
- Conatus Pharmaceuticals Inc.
- Start
- May 2014
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of emricasan in Liver Fibrosis (LF), Liver cirrhosis (LC), sponsored by Conatus Pharmaceuticals Inc.. Started May 2014; status: completed.
02
Drugs
emricasan
03
Conditions
Liver Fibrosis (LF)Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT02138253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02138253.